Home > Insider Trading > Filing (0001181431-15-001720)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1587221	Zosano Pharma Corp	ZSAN	Pharmaceutical Preparations (2834)	454488360

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1005561	J Peter Barris	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1235112	J Patrick Kerins	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1237289	D Scott Sandell	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1270521	Kittu Krishna Kolluri	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1277631	Forest Baskett	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1302106	D Ryan Drant	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1383389	Nea 12 Gp, Llc	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1383390	Nea Partners 12, Limited Partnership	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No
1383391	New Enterprise Associates 12, Limited Partnership	1954 Greenspring Drive Suite 600 Timonium MD 21093	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-01-30	341,201	$9.35	2,135,082	No	4	C	Direct
Common Stock	Acquisiton	2015-01-30	23,457	$11.00	2,158,539	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Price	Price - 2
Common Stock	8% Convertible Note Issued 9/9/2013	Disposition	2015-01-30	$0.00	$0.00
Common Stock	8% Convertible Note Issued 2/26/14	Disposition	2015-01-30	$0.00	$0.00
Common Stock	8% Convertible Note Issued 12/2/2014	Disposition	2015-01-30	$0.00	$0.00

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2015-03-31	No	4	C	Direct
2015-03-31	No	4	C	Direct
2015-03-31	No	4	C	Direct

Footnotes

The outstanding principal and accrued interest on the Convertible Notes automatically converted into shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering at 85% of the Issuer's initial public offering price per share.
The securities are directly held by New Enterprise Associates 12, Limited Partnership ("NEA 12") and indirectly held by NEA Partners 12, Limited Partnership ("NEA Partners 12"), the sole general partner of NEA 12, NEA 12 GP, LLC ("NEA 12 GP"), the sole general partner of NEA Partners 12, and the individual managers of NEA 12 GP (NEA Partners 12, NEA 12 GP and the individual managers of NEA 12 GP together, the "NEA 12 Indirect Reporting Persons"). The individual managers of NEA 12 GP are M. James Barrett, Peter J. Barris, Forest Baskett, Ryan D. Drant, Patrick J. Kerins, Krishna "Kittu" Kolluri, and Scott D. Sandell. The NEA 12 Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 12 shares in which the NEA 12 Indirect Reporting Persons have no pecuniary interest.